Calender
News
Ruim half miljoen euro naar samenwerking MKB en wetenschap
IBOS SME IsoBionics has won the BioBusiness Award 2008
IBOS SME IsoBionics has won the BioBusiness Award 2008
Events
15-17 May 2011 IBOS Open Conference
Publication
Interview with Jan van Hest: Nature as an inspiration, InterACTS Volume 3 no.1
More Chemistry? Visit the NWO-CW website
IBOS
|
IBOS Open Conference, 15-17 May 2011 Lunteren, The Netherlands |
Integration of Biosynthesis and Organic Synthesis.
Duration
2003 – 2012
Aim
IBOS (Integration of Biosynthesis and Organic Synthesis) aims at a change of strategy in synthetic chemistry by integrating state of the art organic chemistry and modern biochemistry and biotechnology. This will enable a new and sustainable future for more efficient industrial synthesis of ever more complex products, hand in hand with a drastic reduction of waste products.
Theme
The programme focuses on the following research lines:
• Molecular Biology & Biosynthesis
• Bio-transformations
• Bio-inspired Organic Synthesis
• Bioprocess Engineering
Budget
M€ 13,6
Financing
NWO (M€ 4,54: NWO General Board M€ 2,27 and NWO Chemical Sciences M€ 2,27), Ministry of Economic Affairs (M€ 4,54), chemical and life sciences industry (M€ 4,54)
Partners
DSM, MSD, Friesland Foods, Solvay Pharmaceuticals, ICI (AkzoNobel), Syncom, Synthon, Applikon, Sanquin Reagents, Chiralix, ProSensa, CLEA Technologies, Dafra Pharma International, Encapson, SyMO-Chem, Isobionics, Enzyscreen, ProteoNic
Background
More about IBOS